Search results (3018)
« Back to PublicationsReport of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.
Journal article
Hausdorff WP. et al, (2026), Vaccine, 75
The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.
Journal article
Abu-Helalah M. et al, (2026), Pediatr Infect Dis J, 45, 229 - 235
Severe necrotizing soft tissue infections (SENSEI) study: Protocol for a multi-centered audit.
Journal article
Yoshimura R. et al, (2026), JPRAS Open, 48, 331 - 336
Securing the future of immunisation: ESCMID’s vision
Journal article
Ramasamy MN. et al, (2026), CMI Communications, 3, 105167 - 105167
Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and Scotland.
Journal article
O'Hagan S. et al, (2026), Arch Dis Child
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UK.
Journal article
Kudowa E. et al, (2026), NPJ Vaccines
n Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.
Journal article
Dold C. et al, (2026), Mol Ther
Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections
Preprint
Hagedoorn N. et al, (2026)
Controlled human pneumococcal infection in the Netherlands: Colonisation, antibody responses and the impact of viral co-infection.
Journal article
van Beek LF. et al, (2026), J Infect, 92
Maternal iron status and total immunoglobulin-G influence transplacental antibody transfer across eight diverse geographical settings.
Journal article
Tiley KS. et al, (2026), Vaccine, 73
Enablers and barriers to participation in vaccine trials: a narrative synthesis.
Journal article
Daniel N. et al, (2026), Vaccine, 73
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.
Journal article
Liatsikos K. et al, (2026), Lancet Microbe
isk to child health: confusion and concern over changes to US vaccine policy.
Journal article
Pollard AJ. and Plotkin S., (2026), Lancet, 407, 553 - 556
Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy.
Journal article
Turkalj S. et al, (2026), Blood, 147, 613 - 632
En-risk to de-risk: An iterative human factors framework for scale development in emerging technologies.
Journal article
Kantor J. et al, (2026), JAAD Int, 24, 342 - 345